"Das Klinikum Hanau ist ein Krankenhaus der höchsten Versorgungsstufe und akademisches Lehrkrankenhaus der Goethe-Universität Frankfurt mit zertifiziertem Ausbildungszentrum. Es verfügt über 13 Kliniken, drei Instituten und einer zentralen Notaufnahme. Das Klinikum Hanau ist mit einer Vielzahl an zertifizierten Zentren diagnostisch auf hohem Niveau – darunter ein Perinatalzentrum Level 1 (Versorgung von Früh- und Neugeborene). Durch das Darmzentrum, das gynäkologische Krebszentrum sowie das Brustzentrum ist es ein Haus mit onkologischem Schwerpunkt. Die zertifizierte Stroke Unit, das Gefäßzentrum sowie das Adipositaszentrum und runden das Angebot ab. Das Klinikum befindet sich in kommunaler Trägerschaft der Stadt Hanau."

During the past decade, Klinikum Hanau GmbH conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Hanau GmbH" #1 sponsor was "University of Ulm" with 5 trials, followed by "German Breast Group" with 2 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored and "AGO Research GmbH" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Hanau GmbH" #1 collaborator was "Austrian Breast & Colorectal Cancer Study Group" with 2 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Hanau GmbH" are "Acute Myeloid Leukemia (AML)" (4 trials), "Acute Myeloid Leukemia" (3 trials), "Breast Cancer" (2 trials), "Lymphoma" (2 trials) and "Myelodysplastic Syndrome With Excess Blasts-2" (2 trials). Many other conditions were trialed in "Klinikum Hanau GmbH" in a lesser frequency.

Most popular intervention types in "Klinikum Hanau GmbH" are "Drug" (15 trials), "Biological" (3 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Cytarabine" (3 trials), "Bevacizumab" (2 trials), "Dasatinib" (2 trials) and "Idarubicin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Hanau GmbH" are 14 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Hanau GmbH". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Klinikum Hanau GmbH, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Hanau GmbH, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".